GeneXpert 在中低收入国家结核检测中的应用:系统评价。
Implementation of GeneXpert for TB Testing in Low- and Middle-Income Countries: A Systematic Review.
机构信息
School of Public Health, Curtin University, Perth, Western Australia, Australia.
出版信息
Glob Health Sci Pract. 2021 Sep 30;9(3):698-710. doi: 10.9745/GHSP-D-21-00121.
INTRODUCTION
Current evidence indicates that the impact of GeneXpert for diagnosing TB in low- and middle-income countries (LMICs) has not demonstrated equivalent outcomes when compared to Xpert evaluations in upper-middle-income countries. Challenges associated with implementation are possible contributing factors preventing this innovative diagnostic technology from achieving more significant public health outcomes. This review aimed to assess the use of implementation science frameworks when reporting the enablers and barriers for the implementation of GeneXpert for diagnosing TB in LMICs.
METHODS
We conducted a qualitative systematic review of the peer-reviewed literature using PubMed, Medline, and Scopus. Eligible articles were those published between January 2010 and March 2020 that identified enablers and barriers to GeneXpert implementation, as well as the implementation approach delivered in an LMIC.
RESULTS
Eleven studies were included in the review. Implementation barriers were found to be relatively consistent across studies and included patient-level factors, human resources, material resources, service implementation, service coordination, and technical operations. Few studies (n=5) identified enabling factors in the implementation of Xpert for TB testing. Identified enablers included strategies such as active case finding, expanding diagnostic algorithms, and daily transport of samples. The public health impact of Xpert TB testing interventions was commonly influenced by implementation barriers (n=4). Of the 11 studies, only 3 reported against an implementation framework.
CONCLUSION
This review identified a commonality in implementation barriers and enablers that influenced the overall public health impact of GeneXpert. With greater transparency of these barriers and enablers, program planners can promote a more collaborative approach and adapt interventions. It is recommended that program planners use implementation science frameworks when conducting research and publishing. This will build an evidence base focused on implementation and thereby support programs to address implementation barriers and include enabling factors in program design.
简介
现有证据表明,与中高收入国家(UMICs)的 Xpert 评估相比,GeneXpert 在中低收入国家(LMICs)诊断结核病的效果并未显示出同等的结果。实施过程中面临的挑战可能是阻碍这种创新诊断技术取得更显著公共卫生成果的因素之一。本综述旨在评估在报告 GeneXpert 在 LMICs 中诊断结核病的实施障碍和促进因素时,使用实施科学框架的情况。
方法
我们使用 PubMed、Medline 和 Scopus 对同行评议文献进行了定性系统综述。符合条件的文章是指 2010 年 1 月至 2020 年 3 月期间发表的文章,这些文章确定了 GeneXpert 实施的障碍和促进因素,以及在 LMIC 中实施的方法。
结果
综述共纳入 11 项研究。研究发现,实施障碍在各研究中相对一致,包括患者因素、人力资源、物质资源、服务实施、服务协调和技术操作。很少有研究(n=5)确定了 Xpert 结核病检测实施中的促进因素。确定的促进因素包括主动病例发现、扩大诊断算法和样本的日常运输等策略。Xpert 结核病检测干预措施的公共卫生影响通常受到实施障碍的影响(n=4)。在这 11 项研究中,只有 3 项报告了实施框架。
结论
本综述确定了影响 GeneXpert 整体公共卫生影响的实施障碍和促进因素的共性。对这些障碍和促进因素的认识更加清晰,规划人员可以促进更具协作性的方法,并调整干预措施。建议规划人员在进行研究和发表文章时使用实施科学框架。这将建立一个专注于实施的证据基础,从而支持项目解决实施障碍,并在项目设计中纳入促进因素。